388 related articles for article (PubMed ID: 29431209)
21. The role of mast cells and basophils in inflammation.
Holgate ST
Clin Exp Allergy; 2000 Jun; 30 Suppl 1():28-32. PubMed ID: 10849471
[TBL] [Abstract][Full Text] [Related]
22. [The role of mast cells and basophils in the pathogenesis of bronchial asthma].
Morita Y; Hirai K; Koshino T; Yamaguchi M; Suzuki M; Nakajima K; Kitani S; Takaishi T; Miyamoto Y; Arai Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():147-53. PubMed ID: 8007458
[TBL] [Abstract][Full Text] [Related]
23. Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media.
Genovese A; Stellato C; Marsella CV; Adt M; Marone G
Int Arch Allergy Immunol; 1996 May; 110(1):13-22. PubMed ID: 8645973
[TBL] [Abstract][Full Text] [Related]
24. Histamine Release from Mast Cells and Basophils.
Borriello F; Iannone R; Marone G
Handb Exp Pharmacol; 2017; 241():121-139. PubMed ID: 28332048
[TBL] [Abstract][Full Text] [Related]
25. What we know (and don't know) about the biology and functions of mast cells and basophils.
Maurer M; Pucillo C
Immunol Rev; 2018 Mar; 282(1):5-7. PubMed ID: 29431213
[No Abstract] [Full Text] [Related]
26. Basophils and mast cells in airway inflammation and asthma.
Denburg JA
Can Respir J; 1998; 5 Suppl A():41A-4A. PubMed ID: 9753516
[TBL] [Abstract][Full Text] [Related]
27. Markers of mast cell degranulation.
Hogan AD; Schwartz LB
Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
[TBL] [Abstract][Full Text] [Related]
28. Anaphylaxis: mechanisms of mast cell activation.
Kalesnikoff J; Galli SJ
Chem Immunol Allergy; 2010; 95():45-66. PubMed ID: 20519881
[TBL] [Abstract][Full Text] [Related]
29. CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation.
Sabato V; Verweij MM; Bridts CH; Levi-Schaffer F; Gibbs BF; De Clerck LS; Schiavino D; Ebo DG
Cytometry B Clin Cytom; 2012 May; 82(3):132-8. PubMed ID: 22173928
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of basophil activation by histamine: a sensitive and reproducible model for the study of the biological activity of high dilutions.
Sainte-Laudy J; Belon P
Homeopathy; 2009 Oct; 98(4):186-97. PubMed ID: 19945674
[TBL] [Abstract][Full Text] [Related]
31. The role of mast cell and basophil activation in human allergic reactions.
Marone G
Eur Respir J Suppl; 1989 Jun; 6():446s-455s. PubMed ID: 2679595
[TBL] [Abstract][Full Text] [Related]
32. Molecular and cellular biology of mast cells and basophils.
Marone G; Casolaro V; Patella V; Florio G; Triggiani M
Int Arch Allergy Immunol; 1997 Nov; 114(3):207-17. PubMed ID: 9363900
[TBL] [Abstract][Full Text] [Related]
33. Improvement of flow cytometric analysis of basophil activation inhibition by high histamine dilutions. A novel basophil specific marker: CD 203c.
Sainte-Laudy J; Belon P
Homeopathy; 2006 Jan; 95(1):3-8. PubMed ID: 16399248
[TBL] [Abstract][Full Text] [Related]
34. Regulation of human mast cell and basophil function by cAMP.
Weston MC; Peachell PT
Gen Pharmacol; 1998 Nov; 31(5):715-9. PubMed ID: 9809467
[TBL] [Abstract][Full Text] [Related]
35. SHIP1 and the negative control of mast cell/basophil activation by supra-optimal antigen concentrations.
Huber M; Gibbs BF
Mol Immunol; 2015 Jan; 63(1):32-7. PubMed ID: 24679713
[TBL] [Abstract][Full Text] [Related]
36. [Mast cells and basophilic leukocytes in allergic inflammation].
Bukilica M; Bogić M; Andrejević S; Nikolić B
Srp Arh Celok Lek; 1997; 125(11-12):363-9. PubMed ID: 9480572
[TBL] [Abstract][Full Text] [Related]
37. Omalizumab may not inhibit mast cell and basophil activation in vitro.
Gericke J; Ohanyan T; Church MK; Maurer M; Metz M
J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1832-6. PubMed ID: 25257818
[TBL] [Abstract][Full Text] [Related]
38. Basophil markers for identification and activation in the indirect basophil activation test by flow cytometry for diagnosis of autoimmune urticaria.
Kim Z; Choi BS; Kim JK; Won DI
Ann Lab Med; 2016 Jan; 36(1):28-35. PubMed ID: 26522756
[TBL] [Abstract][Full Text] [Related]
39. Mast cell proteases as pharmacological targets.
Caughey GH
Eur J Pharmacol; 2016 May; 778():44-55. PubMed ID: 25958181
[TBL] [Abstract][Full Text] [Related]
40. Pediatric Expression of Mast Cell Activation Disorders.
Broesby-Olsen S; Carter M; Kjaer HF; Mortz CG; Møller MB; Kristensen TK; Bindslev-Jensen C; Agertoft L
Immunol Allergy Clin North Am; 2018 Aug; 38(3):365-377. PubMed ID: 30007457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
